The tumor suppressor CDKN3 controls mitosis

Journal of Cell Biology

Volumn 201, Issue 7, 2013, Pages 997-1012

  Nalepa, Grzegorz ^a   Barnholtz Sloan, Jill ^b   Enzor, Rikki ^a   Dey, Dilip ^a   He, Ying ^a   Gehlhausen, Jeff R ^a   Lehmann, Amalia S ^a   Park, Su Jung ^a   Yang, Yanzhu ^a   Yang, Xianlin ^a   Chen, Shi ^a   Guan, Xiaowei ^b   Chen, Yanwen ^b   Renbarger, Jamie ^a   Yang, Feng Chun ^a   Parada, Luis F ^c   Clapp, Wade ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN3 PROTEIN; CYCLIN DEPENDENT KINASE 1; SERINE; THREONINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TUMOR; CELLULAR DISTRIBUTION; CENTROMERE; CENTROSOME; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MASS SPECTROMETRY; MITOSIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CENTROSOME; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DUAL-SPECIFICITY PHOSPHATASES; HELA CELLS; HUMANS; KINETOCHORES; MASS SPECTROMETRY; MITOSIS; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84880054523     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201205125     Document Type: Article

References (97)

1. Azzam, R., S.L. Chen, W. Shou, A.S. Mah, G. Alexandru, K. Nasmyth, R.S. Annan, S.A. Carr, and R.J. Deshaies. 2004. Phosphorylation by cyclin B-Cdk underlies release of mitotic exit activator Cdc14 from the nucleolus. Science. 305:516-519. http://dx.doi.org/10.1126/science.1099402
2. Bielas, S.L., J.L. Silhavy, F. Brancati, M.V. Kisseleva, L. Al-Gazali, L. Sztriha, R.A. Bayoumi, M.S. Zaki, A. Abdel-Aleem, R.O. Rosti, et al. 2009. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41:1032-1036. http://dx.doi.org/10.1038/ng.423
3. Blenk, S., J. Engelmann, M. Weniger, J. Schultz, M. Dittrich, A. Rosenwald, H.K. Müller-Hermelink, T. Müller, and T. Dandekar. 2007. Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform. 3:399-420.
4. Bouchoux, C., and F. Uhlmann. 2011. A quantitative model for ordered Cdk substrate dephosphorylation during mitotic exit. Cell. 147:803-814. http://dx.doi.org/10.1016/j.cell.2011.09.047
5. Burgess, A., S. Vigneron, E. Brioudes, J.C. Labbé, T. Lorca, and A. Castro. 2010. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. USA. 107:12564-12569. http://dx.doi.org/10.1073/pnas.0914191107
6. Cahill, D.P., C. Lengauer, J. Yu, G.J. Riggins, J.K. Willson, S.D. Markowitz, K.W. Kinzler, and B. Vogelstein. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:300-303. http://dx.doi.org/10.1038/32688
7. Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 455:1061-1068. http://dx.doi.org/10.1038/nature07385
8. Chan, Y.W., H.T. Ma, W. Wong, C.C. Ho, K.F. On, and R.Y. Poon. 2008. CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle. 7:1449-1461. http://dx.doi.org/10.4161/cc.7.10.5880
9. Clarke, P.R., and C. Zhang. 2008. Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 9:464-477. http://dx.doi.org/10.1038/nrm2410
10. Crasta, K., N.J. Ganem, R. Dagher, A.B. Lantermann, E.V. Ivanova, Y. Pan, L. Nezi, A. Protopopov, D. Chowdhury, and D. Pellman. 2012. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 482:53-58. http://dx.doi.org/10.1038/nature10802
11. D'Angiolella, V., C. Mari, D. Nocera, L. Rametti, and D. Grieco. 2003. The spindle checkpoint requires cyclin-dependent kinase activity. Genes Dev. 17:2520-2525. http://dx.doi.org/10.1101/gad.267603
12. Dai, W., Q. Wang, T. Liu, M. Swamy, Y. Fang, S. Xie, R. Mahmood, Y.M. Yang, M. Xu, and C.V. Rao. 2004. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 64:440-445. http://dx.doi.org/10.1158/0008-5472.CAN-03-3119
13. De Smedt, V., R. Poulhe, X. Cayla, F. Dessauge, A. Karaiskou, C. Jessus, and R. Ozon. 2002. Thr-161 phosphorylation of monomeric Cdc2. Regulation by protein phosphatase 2C in Xenopus oocytes. J. Biol. Chem. 277:28592-28600. http://dx.doi.org/10.1074/jbc.M202742200
14. De Souza, C.P., K.A. Ellem, and B.G. Gabrielli. 2000. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp. Cell Res. 257:11-21. http://dx.doi.org/10.1006/excr.2000.4872
15. De Wulf, P., F. Montani, and R. Visintin. 2009. Protein phosphatases take the mitotic stage. Curr. Opin. Cell Biol. 21:806-815. http://dx.doi.org/10.1016/j.ceb.2009.08.003
16. Dobles, M., V. Liberal, M.L. Scott, R. Benezra, and P.K. Sorger. 2000. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell. 101:635-645. http://dx.doi.org/10.1016/S0092-8674(00)80875-2
17. Eichhorn, P.J., L. Rodón, A. González-Juncá, A. Dirac, M. Gili, E. Martínez-Sáez, C. Aura, I. Barba, V. Peg, A. Prat, et al. 2012. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat. Med. 18:429-435. http://dx.doi.org/10.1038/nm.2619
18. Ganem, N.J., S.A. Godinho, and D. Pellman. 2009. A mechanism linking extra centrosomes to chromosomal instability. Nature. 460:278-282. http://dx.doi.org/10.1038/nature08136
19. Gautier, J., M.J. Solomon, R.N. Booher, J.F. Bazan, and M.W. Kirschner. 1991. cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell. 67:197-211. http://dx.doi.org/10.1016/0092-8674(91)90583-K
20. Gharbi-Ayachi, A., J.C. Labbé, A. Burgess, S. Vigneron, J.M. Strub, E. Brioudes, A. Van-Dorsselaer, A. Castro, and T. Lorca. 2010. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science. 330:1673-1677. http://dx.doi.org/10.1126/science.1197048
21. Gordon, D.J., B. Resio, and D. Pellman. 2012. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13:189-203.
22. Groigno, L., and M. Whitaker. 1998. An anaphase calcium signal controls chromosome disjunction in early sea urchin embryos. Cell. 92:193-204. http://dx.doi.org/10.1016/S0092-8674(00)80914-9
23. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 75:791-803. http://dx.doi.org/10.1016/0092-8674(93)90498-F
24. Habrukowich, C., D.K. Han, A. Le, K. Rezaul, W. Pan, M. Ghosh, Z. Li, K. Dodge-Kafka, X. Jiang, R. Bittman, and T. Hla. 2010. Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells. J. Biol. Chem. 285:26825-26831. http://dx.doi.org/10.1074/jbc.M110.147058
25. Hanahan, D., and R.A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell. 144:646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
26. Hanks, S., K. Coleman, S. Reid, A. Plaja, H. Firth, D. Fitzpatrick, A. Kidd, K. Méhes, R. Nash, N. Robin, et al. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36:1159-1161. http://dx.doi.org/10.1038/ng1449
27. Hannon, G.J., D. Casso, and D. Beach. 1994. KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA. 91:1731-1735. http://dx.doi.org/10.1073/pnas.91.5.1731
28. Hériché, J.K., F. Lebrin, T. Rabilloud, D. Leroy, E.M. Chambaz, and Y. Goldberg. 1997. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science. 276:952-955. http://dx.doi.org/10.1126/science.276.5314.952
29. Hoyt, M.A., L. Totis, and B.T. Roberts. 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 66:507-517. http://dx.doi.org/10.1016/0092-8674(81)90014-3
30. Hübner, N.C., L.H. Wang, M. Kaulich, P. Descombes, I. Poser, and E.A. Nigg. 2010. Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs. Chromosoma. 119:149-165. http://dx.doi.org/10.1007/s00412-009-0244-2
31. Hümmer, S., and T.U. Mayer. 2009. Cdk1 negatively regulates midzone localization of the mitotic kinesin Mklp2 and the chromosomal passenger complex. Curr. Biol. 19:607-612. http://dx.doi.org/10.1016/j.cub.2009.02.046
32. Jacoby, M., J.J. Cox, S. Gayral, D.J. Hampshire, M. Ayub, M. Blockmans, E. Pernot, M.V. Kisseleva, P. Compére, S.N. Schiffmann, et al. 2009.INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41:1027-1031. http://dx.doi.org/10.1038/ng.427
33. Jiang, R., Y. Xia, J. Li, L. Deng, L. Zhao, J. Shi, X. Wang, and B. Sun. 2010. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. Int. J. Cancer. 126:1263-1274.
34. Kops, G.J., D.R. Foltz, and D.W. Cleveland. 2004. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl. Acad. Sci. USA. 101:8699-8704. http://dx.doi.org/10.1073/pnas.0401142101
35. Kotadia, S., L.R. Kao, S.A. Comerford, R.T. Jones, R.E. Hammer, and T.L. Megraw. 2008. PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen. Oncogene. 27:6334-6346. http://dx.doi.org/10.1038/onc.2008.254
36. Lai, M.W., T.C. Chen, S.T. Pang, and C.T. Yeh. 2012. Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells. Urol. Oncol. 30:871-878. http://dx.doi.org/10.1016/j.urolonc.2010.09.010
37. Lee, S.W., C.L. Reimer, L. Fang, M.L. Iruela-Arispe, and S.A. Aaronson. 2000. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol. Cell. Biol. 20:1723-1732. http://dx.doi.org/10.1128/MCB.20.5.1723-1732.2000
38. Lee, S.H., F. McCormick, and H. Saya. 2010. Mad2 inhibits the mitotic kinesin MKlp2. J. Cell Biol. 191:1069-1077. http://dx.doi.org/10.1083/jcb.201003095
39. Li, R., and A.W. Murray. 1991. Feedback control of mitosis in budding yeast. Cell. 66:519-531. http://dx.doi.org/10.1016/0092-8674(81)90015-5
40. Lindqvist, A., V. Rodríguez-Bravo, and R.H. Medema. 2009. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell Biol. 185:193-202. http://dx.doi.org/10.1083/jcb.200812045
41. Litchfield, D.W., B. Lüscher, F.J. Lozeman, R.N. Eisenman, and E.G. Krebs. 1992. Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J. Biol. Chem. 267:13943-13951.
42. Liu, Y., M. Boukhelifa, E. Tribble, E. Morin-Kensicki, A. Uetrecht, J.E. Bear, and V.A. Bankaitis. 2008. The Sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals. Mol. Biol. Cell. 19:3080-3096. http://dx.doi.org/10.1091/mbc.E07-12-1290
43. López-Avilés, S., O. Kapuy, B. Novák, and F. Uhlmann. 2009. Irreversibility of mitotic exit is the consequence of systems-level feedback. Nature. 459:592-595. http://dx.doi.org/10.1038/nature07984
44. Lorca, T., J.C. Labbé, A. Devault, D. Fesquet, J.P. Capony, J.C. Cavadore, F. Le Bouffant, and M. Dorée. 1992. Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J. 11:2381-2390.
45. Lundgren, D.H., H. Martinez, M.E. Wright, and D.K. Han. 2009. Protein identification using Sorcerer 2 and SEQUEST. Curr. Protoc. Bioinformatics. Chapter 13:13: 3.
46. Manchado, E., M. Guillamot, G. de Cárcer, M. Eguren, M. Trickey, I. García-Higuera, S. Moreno, H. Yamano, M. Cañamero, and M. Malumbres. 2010. Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase. Cancer Cell. 18:641-654. http://dx.doi.org/10.1016/j.ccr.2010.10.028
47. Mayer, T.U., T.M. Kapoor, S.J. Haggarty, R.W. King, S.L. Schreiber, and T.J. Mitchison. 1999. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science. 286:971-974. http://dx.doi.org/10.1126/science.286.5441.971
48. Meraldi, P., V.M. Draviam, and P.K. Sorger. 2004. Timing and checkpoints in the regulation of mitotic progression. Dev. Cell. 7:45-60. http://dx.doi.org/10.1016/j.devcel.2004.06.006
49. Michel, L.S., V. Liberal, A. Chatterjee, R. Kirchwegger, B. Pasche, W. Gerald, M. Dobles, P.K. Sorger, V.V. Murty, and R. Benezra. 2001. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 409:355-359. http://dx.doi.org/10.1038/35053094
50. Mir, S.E., P.C. De Witt Hamer, P.M. Krawczyk, L. Balaj, A. Claes, J.M. Niers, A.A. Van Tilborg, A.H. Zwinderman, D. Geerts, G.J. Kaspers, et al. 2010. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell. 18:244-257. http://dx.doi.org/10.1016/j.ccr.2010.08.011
51. Mocciaro, A., and E. Schiebel. 2010. Cdc14: a highly conserved family of phosphatases with non-conserved functions? J. Cell Sci. 123:2867-2876. http://dx.doi.org/10.1242/jcs.074815
52. Mochida, S., S.L. Maslen, M. Skehel, and T. Hunt. 2010. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science. 330:1670-1673. http://dx.doi.org/10.1126/science.1195689
53. Musacchio, A., and E.D. Salmon. 2007. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8:379-393. http://dx.doi.org/10.1038/nrm2163
54. Nalepa, G., M. Rolfe, and J.W. Harper. 2006. Drug discovery in the ubiquitin-proteasome system. Nat. Rev. Drug Discov. 5:596-613. http://dx.doi.org/10.1038/nrd2056
55. Neef, R., U. Gruneberg, R. Kopajtich, X. Li, E.A. Nigg, H. Sillje, and F.A. Barr. 2007. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1. Nat. Cell Biol. 9:436-444. http://dx.doi.org/10.1038/ncb1557
56. Nethercott, H., M. Sheridan, and P.H. Schwartz. 2007. Neural Stem Cell Culture. In Human Stem Cell Manual. J. Loring, editor. Academic Press, London. 311-333.
57. Neviani, P., R. Santhanam, R. Trotta, M. Notari, B.W. Blaser, S. Liu, H. Mao, J.S. Chang, A. Galietta, A. Uttam, et al. 2005. The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer Cell. 8:355-368. http://dx.doi.org/10.1016/j.ccr.2005.10.015
58. Niculescu, M.D., Y. Yamamuro, and S.H. Zeisel. 2004. Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J. Neurochem. 89:1252-1259. http://dx.doi.org/10.1111/j.1471-4159.2004.02414.x
59. Ohba, S., K. Shimizu, S. Shibao, T. Miwa, T. Nakagawa, H. Sasaki, and H. Murakami. 2011. A glioblastoma arising from the attached region where a meningioma had been totally removed. Neuropathology. 31:606-611. http://dx.doi.org/10.1111/j.1440-1789.2011.01198.x
60. Padua, M.B., and P.J. Hansen. 2009. Changes in expression of cell-cycle-related genes in PC-3 prostate cancer cells caused by ovine uterine serpin. J. Cell. Biochem. 107:1182-1188. http://dx.doi.org/10.1002/jcb.22222
61. Parsons, D.W., S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science. 321:1807-1812. http://dx.doi.org/10.1126/science.1164382
62. Poon, R.Y., and T. Hunter. 1995. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science. 270:90-93. http://dx.doi.org/10.1126/science.270.5233.90
63. Queralt, E., C. Lehane, B. Novak, and F. Uhlmann. 2006. Downregulation of PP2A(Cdc55) phosphatase by separase initiates mitotic exit in budding yeast. Cell. 125:719-732. http://dx.doi.org/10.1016/j.cell.2006.03.038
64. Reis, R., T. Feijão, S. Gouveia, A.J. Pereira, I. Matos, P. Sampaio, H. Maiato, and C.E. Sunkel. 2009. Dynein and mast/orbit/CLASP have antagonistic roles in regulating kinetochore-microtubule plus-end dynamics. J. Cell Sci. 122:2543-2553. http://dx.doi.org/10.1242/jcs.044818
65. Rodriguez-Viciana, P., C. Collins, and M. Fried. 2006. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc. Natl. Acad. Sci. USA. 103:19290-19295. http://dx.doi.org/10.1073/pnas.0609343103
66. Rush, J., A. Moritz, K.A. Lee, A. Guo, V.L. Goss, E.J. Spek, H. Zhang, X.M. Zha, R.D. Polakiewicz, and M.J. Comb. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23:94-101. http://dx.doi.org/10.1038/nbt1046
67. Sablina, A.A., W. Chen, J.D. Arroyo, L. Corral, M. Hector, S.E. Bulmer, J.A. DeCaprio, and W.C. Hahn. 2007. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell. 129:969-982. http://dx.doi.org/10.1016/j.cell.2007.03.047
68. Sablina, A.A., M. Hector, N. Colpaert, and W.C. Hahn. 2010. Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res. 70:10474-10484. http://dx.doi.org/10.1158/0008-5472.CAN-10-2855
69. Sawin, K.E., K. LeGuellec, M. Philippe, and T.J. Mitchison. 1992. Mitotic spindle organization by a plus-end-directed microtubule motor. Nature. 359:540-543. http://dx.doi.org/10.1038/359540a0
70. Schlaitz, A.L., M. Srayko, A. Dammermann, S. Quintin, N. Wielsch, I. MacLeod, Q. de Robillard, A. Zinke, J.R. Yates III, T. Müller-Reichert, et al. 2007. The C. elegans RSA complex localizes protein phosphatase 2A to centrosomes and regulates mitotic spindle assembly. Cell. 128:115-127. http://dx.doi.org/10.1016/j.cell.2006.10.050
71. Schmitz, M.H., M. Held, V. Janssens, J.R. Hutchins, O. Hudecz, E. Ivanova, J. Goris, L. Trinkle-Mulcahy, A.I. Lamond, I. Poser, et al. 2010. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 12:886-893. http://dx.doi.org/10.1038/ncb2092
72. Schwartz, P.H., P.J. Bryant, T.J. Fuja, H. Su, D.K. O'Dowd, and H. Klassen. 2003. Isolation and characterization of neural progenitor cells from post-mortem human cortex. J. Neurosci. Res. 74:838-851. http://dx.doi.org/10.1002/jnr.10854
73. Shou, W., J.H. Seol, A. Shevchenko, C. Baskerville, D. Moazed, Z.W. Chen, J. Jang, A. Shevchenko, H. Charbonneau, and R.J. Deshaies. 1999. Exitfrom mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell. 97:233-244. http://dx.doi.org/10.1016/S0092-8674(00)80733-3
74. Sigoillot, F.D., S. Lyman, J.F. Huckins, B. Adamson, E. Chung, B. Quattrochi, and R.W. King. 2012. A bioinformatics method identifies prominent offtargeted transcripts in RNAi screens. Nat. Methods. 9:363-366. http://dx.doi.org/10.1038/nmeth.1898
75. Song, H., N. Hanlon, N.R. Brown, M.E. Noble, L.N. Johnson, and D. Barford. 2001. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Mol. Cell. 7:615-626. http://dx.doi.org/10.1016/S1097-2765(01)00208-8
76. Sotillo, R., E. Hernando, E. Díaz-Rodríguez, J. Teruya-Feldstein, C. Cordón-Cardo, S.W. Lowe, and R. Benezra. 2007. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell. 11:9-23. http://dx.doi.org/10.1016/j.ccr.2006.10.019
77. Sotillo, R., J.M. Schvartzman, N.D. Socci, and R. Benezra. 2010. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature. 464:436-440. http://dx.doi.org/10.1038/nature08803
78. St-Denis, N.A., and D.W. Litchfield. 2009. Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 66:1817-1829. http://dx.doi.org/10.1007/s00018-009-9150-2
79. Stokes, M.P., C.L. Farnsworth, A. Moritz, J.C. Silva, X. Jia, K.A. Lee, A. Guo, R.D. Polakiewicz, and M.J. Comb. 2012. PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol. Cell. Proteomics. 11:187-201. http://dx.doi.org/10.1074/mcp.M111.015883
80. Stupp, R., W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987-996. http://dx.doi.org/10.1056/NEJMoa043330
81. Sudakin, V., G.K. Chan, and T.J. Yen. 2001. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154:925-936. http://dx.doi.org/10.1083/jcb.200102093
82. Tao, W., V.J. South, Y. Zhang, J.P. Davide, L. Farrell, N.E. Kohl, L. Sepp-Lorenzino, and R.B. Lobell. 2005. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell. 8:49-59. http://dx.doi.org/10.1016/j.ccr.2005.06.003
83. Taylor, K.J., A.H. Sims, L. Liang, D. Faratian, M. Muir, G. Walker, B. Kuske, J.M. Dixon, D.A. Cameron, D.J. Harrison, and S.P. Langdon. 2010. Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res. 12:R39. http://dx.doi.org/10.1186/bcr2593
84. Thompson, S.L., S.F. Bakhoum, and D.A. Compton. 2010. Mechanisms of chromosomal instability. Curr. Biol. 20:R285-R295. http://dx.doi.org/10.1016/j.cub.2010.01.034
85. Tsichlis, P.N., M. Hatziapostolou, and P.W. Hinds. 2007. Timing is everything: regulation of Cdk1 and aneuploidy. Dev. Cell. 12:477-479. http://dx.doi.org/10.1016/j.devcel.2007.03.010
86. Vassilev, L.T., C. Tovar, S. Chen, D. Knezevic, X. Zhao, H. Sun, D.C. Heimbrook, and L. Chen. 2006. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. USA. 103: 10660-10665. http://dx.doi.org/10.1073/pnas.0600447103
87. Visintin, R., K. Craig, E.S. Hwang, S. Prinz, M. Tyers, and A. Amon. 1998. The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. Mol. Cell. 2:709-718. http://dx.doi.org/10.1016/S1097-2765(00)80286-5
88. Westhorpe, F.G., M.A. Diez, M.D. Gurden, A. Tighe, and S.S. Taylor. 2010. Re-evaluating the role of Tao1 in the spindle checkpoint. Chromosoma. 119:371-379. http://dx.doi.org/10.1007/s00412-010-0261-1
89. Wiedemeyer, R., C. Brennan, T.P. Heffernan, Y. Xiao, J. Mahoney, A. Protopopov, H. Zheng, G. Bignell, F. Furnari, W.K. Cavenee, et al. 2008. Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell. 13:355-364. http://dx.doi.org/10.1016/j.ccr.2008.02.010
90. Wiedemeyer, W.R., I.F. Dunn, S.N. Quayle, J. Zhang, M.G. Chheda, G.P. Dunn, L. Zhuang, J. Rosenbluh, S. Chen, Y. Xiao, et al. 2010. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc. Natl. Acad. Sci. USA. 107:11501-11506. http://dx.doi.org/10.1073/pnas.1001613107
91. Wong, A.J., J.M. Ruppert, S.H. Bigner, C.H. Grzeschik, P.A. Humphrey, D.S. Bigner, and B. Vogelstein. 1992. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA. 89:2965-2969. http://dx.doi.org/10.1073/pnas.89.7.2965
92. Wu, J.Q., J.Y. Guo, W. Tang, C.S. Yang, C.D. Freel, C. Chen, A.C. Nairn, and S. Kornbluth. 2009. PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation. Nat. Cell Biol. 11:644-651. http://dx.doi.org/10.1038/ncb1871
93. Wurzenberger, C., and D.W. Gerlich. 2011. Phosphatases: providing safe passage through mitotic exit. Nat. Rev. Mol. Cell Biol. 12:469-482. http://dx.doi.org/10.1038/nrm3149
94. Ye, X., Y. Wei, G. Nalepa, and J.W. Harper. 2003. The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and Cajal body maintenance in human somatic cells. Mol. Cell. Biol. 23:8586-8600. http://dx.doi.org/10.1128/MCB.23.23.8586-8600.2003
95. Yeh, C.T., S.C. Lu, T.C. Chen, C.Y. Peng, and Y.F. Liaw. 2000. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma. Cancer Res. 60:4697-4700.
96. Yu, Y., X. Jiang, B.S. Schoch, R.S. Carroll, P.M. Black, and M.D. Johnson. 2007. Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res. 67:130-138. http://dx.doi.org/10.1158/0008-5472.CAN-06-2478
97. Zhang, H., X. Zha, Y. Tan, P.V. Hornbeck, A.J. Mastrangelo, D.R. Alessi, R.D. Polakiewicz, and M.J. Comb. 2002. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 277:39379-39387. http://dx.doi.org/10.1074/jbc.M206399200